Minor intron splicing is critical for survival of lethal prostate cancer (raw images)

Authors

Rubin, Mark A.

Description

Description from Mendeley Data: "Men with androgen receptor-negative castration-resistant prostate cancer (ARN CRPC) do not benefit from androgen receptor-directed therapies, face low survival rates, and have few alternative therapeutic options. Addressing this unmet clinical need requires new approaches to identify this more aggressive form of disease early on and to treat it effectively. A recent...

Subject

Introns/genetics

Prostatic Neoplasms, Castration-Resistant

Receptors, Androgen

RNAi Therapeutics

Spliceosomes

Access Rights

Free to All